Rat respiratory coronavirus infection: Replication in airway and alveolar epithelial cells and the innate immune response

Journal of General Virology

Volumn 90, Issue 12, 2009, Pages 2956-2964

  Funk, C Joel ^a   Manzer, Rizwan ^a   Miura, Tanya A ^b   Groshong, Steve D ^a   Ito, Yoko ^a   Travanty, Emily A ^a   Leete, Jennifer ^a   Holmes, Kathryn V ^c   Mason, Robert J ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF IDAHO   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEOCAPSID PROTEIN; SURFACTANT PROTEIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CILIATED EPITHELIUM; CLARA CELL; CONTROLLED STUDY; CORONAVIRUS; CYTOKINE PRODUCTION; IMMUNOFLUORESCENCE TEST; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM; LUNG DISEASE; LUNG INFILTRATE; LUNG LAVAGE; MALE; NEUTROPHIL COUNT; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VIRUS REPLICATION; WEIGHT REDUCTION;

ANIMALS; CORONAVIRUS INFECTIONS; CORONAVIRUS, RAT; CYTOKINES; EPITHELIAL CELLS; IMMUNITY, INNATE; LUNG; MALE; PULMONARY ALVEOLI; PULMONARY SURFACTANTS; RATS; RATS, INBRED F344; VIRUS REPLICATION; WEIGHT LOSS;

CORONAVIRUS; RAT CORONAVIRUS; RAT SIALODACRYOADENITIS CORONAVIRUS; RATTUS;

EID: 70849110839     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.014282-0     Document Type: Article

References (52)

1. Alcorn, J. L., Stark, J. M., Chiappetta, C. L., Jenkins, G. & Colasurdo, G. N. (2005). Effects of RSV infection on pulmonary surfactant protein SP-A in cultured human type II cells: contrasting consequences on SP-A mRNA and protein. Am J Physiol Lung Cell Mol Physiol 289, L1113-L1122.
2. Bhatt, P. N., Percy, D. H. & Jonas, A. M. (1972). Characterization of the virus of sialodacryoadenitis of rats: a member of the coronavirus group. J Infect Dis 126, 123-130.
3. Crouch, E. C. (2000). Surfactant protein-D and pulmonary host defense. Respir Res 1, 93-108.
4. De Albuquerque, N., Baig, E., Ma, X., Zhang, J., He, W., Rowe, A., Habal, M., Liu, M., Shalev, I. & other authors (2006). Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. J Virol 80, 10382-10394.
5. Doss, M., White, M. R., Tecle, T., Gantz, D., Crouch, E. C., Jung, G., Ruchala, P., Waring, A. J., Lehrer, R. I. & Hartshorn, K. L. (2009). Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D. J Immunol 182, 7878-7887.
6. Fouchier, R. A., Kuiken, T., Schutten, M., van Amerongen, G., van Doornum, G. J., van den Hoogen, B. G., Peiris, M., Lim, W., Stohr, K. & Osterhaus, A. D. (2003). Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423, 240.
7. Franks, T. J., Chong, P. Y., Chui, P., Galvin, J. R., Lourens, R. M., Reid, A. H., Selbs, E., McEvoy, C. P., Hayden, C. D. & other authors (2003). Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol 34, 743-748.
8. Gagneten, S., Scanga, C. A., Dveksler, G. S., Beauchemin, N., Percy, D. & Holmes, K. V. (1996). Attachment glycoproteins and receptor specificity of rat coronaviruses. Lab Anim Sci 46, 159-166.
9. Gerna, G., Campanini, G., Rovida, F., Percivalle, E., Sarasini, A., Marchi, A. & Baldanti, F. (2006). Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J Med Virol 78, 938-949.
10. Gerna, G., Percivalle, E., Sarasini, A., Campanini, G., Piralla, A., Rovida, F., Genini, E., Marchi, A. & Baldanti, F. (2007). Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients. J Clin Virol 38, 244-250.
11. Grubor, B., Gallup, J. M., Meyerholz, D. K., Crouch, E. C., Evans, R. B., Brogden, K. A., Lehmkuhl, H. D. & Ackermann, M. R. (2004). Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambs. Clin Diagn Lab Immunol 11, 599-607.
12. Haagsman, H. P. (1998). Interactions of surfactant protein A with pathogens. Biochim Biophys Acta 1408, 264-277.
13. Haagsman, H. P., Hogenkamp, A., van Eijk, M. & Veldhuizen, E. J. (2008). Surfactant collectins and innate immunity. Neonatology 93, 288-294.
14. Halbower, A. C., Mason, R. J., Abman, S. H. & Tuder, R. M. (1994). Agarose infiltration improves morphology of cryostat sections of lung. Lab Invest 71, 149-153.
15. Huang, K. J., Su, I. J., Theron, M., Wu, Y. C., Lai, S. K., Liu, C. C. & Lei, H. Y. (2005). An interferon-gamma-related cytokine storm in SARS patients. J Med Virol 75, 185-194.
16. Johnston, S. L. (2005). Overview of virus-induced airway disease. Proc Am Thorac Soc 2, 150-156.
17. Kahn, J. S. & McIntosh, K. (2005). History and recent advances in coronavirus discovery. Pediatr Infect Dis J 24, S223-S227.
18. Kahn, J. S. (2006). The widening scope of coronaviruses. Curr Opin Pediatr 18, 42-47.
19. Kesson, A. M. (2007). Respiratory virus infections. Paediatr Respir Rev 8, 240-248.
20. Khanolkar, A., Hartwig, S. M., Haag, B. A., Meyerholz, D. K., Harty, J. T. & Varga, S. M. (2009). Toll-like receptor 4 deficiency increases disease and mortality after mouse hepatitis virus type 1 infection of susceptible C3H mice. J Virol 83, 8946-8956.
21. Leth-Larsen, R., Zhong, F., Chow, V. T., Holmskov, U. & Lu, J. (2007). The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages. Immunobiology 212, 201-211.
22. + stem/ progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci U S A 103, 9530-9535.
23. Mason, R. J. (2006). Biology of alveolar type II cells. Respirology 11 (Suppl.), S12-S15.
24. Mason, R. J., Lewis, M. C., Edeen, K. E., McCormick-Shannon, K., Nielsen, L. D. & Shannon, J. M. (2002). Maintenance of surfactant protein A and D secretion by rat alveolar type II cells in vitro. Am J Physiol Lung Cell Mol Physiol 282, L249-L258.
25. Miura, T. A., Wang, J., Mason, R. J. & Holmes, K. V. (2006). Rat coronavirus infection of primary rat alveolar epithelial cells. Adv Exp Med Biol 581, 351-356.
26. Miura, T. A., Wang, J., Holmes, K. V. & Mason, R. J. (2007). Rat coronaviruses infect rat alveolar type I epithelial cells and induce expression of CXC chemokines. Virology 369, 288-298.
27. Mossel, E. C., Wang, J., Jeffers, S., Edeen, K. E., Wang, S., Cosgrove, G. P., Funk, C. J., Manzer, R., Miura, T. A. & other authors (2008). SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells. Virology 372, 127-135.
28. Muller, P. Y., Janovjak, H., Miserez, A. R. & Dobbie, Z. (2002). Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32, 1372-1379.
29. Nagata, N., Iwata, N., Hasegawa, H., Fukushi, S., Yokoyama, M., Harashima, A., Sato, Y., Saijo, M., Morikawa, S. & Sata, T. (2007). Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J Virol 81, 1848-1857.
30. Nicholls, J. M., Poon, L. L., Lee, K. C., Ng, W. F., Lai, S. T., Leung, C. Y., Chu, C. M. , Hui, P. K., Mak, K. L. & other authors (2003). Lung pathology of fatal severe acute respiratory syndrome. Lancet 361, 1773-1778.
31. Nicholls, J. M., Butany, J., Poon, L. L., Chan, K. H., Beh, S. L., Poutanen, S., Peiris, J. S. & Wong, M. (2006). Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med 3, e27.
32. Nichols, W. G., Peck Campbell, A. J. & Boeckh, M. (2008). Respiratory viruses other than influenza virus: impact and therapeutic advances. Clin Microbiol Rev 21, 274-290.
33. Parker, J. C., Cross, S. S. & Rowe, W. P. (1970). Rat coronavirus (RCV): a prevalent, naturally occurring pneumotropic virus of rats. Arch Gesamte Virusforsch 31, 293-302.
34. Pastva, A. M., Wright, J. R. & Williams, K. L. (2007). Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc Am Thorac Soc 4, 252-257.
35. Peiris, J. S., Lai, S. T., Poon, L. L., Guan, Y., Yam, L. Y., Lim, W., Nicholls, J., Yee, W. K., Yan, W. W. & other authors (2003). Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319-1325.
36. Percy, D. H., Williams, K. L. & Paturzo, F. X. (1991). A comparison of the sensitivity and specificity of sialodacryoadenitis virus, Parker's rat coronavirus, and mouse hepatitis virus-infected cells as a source of antigen for the detection of antibody to rat coronaviruses. Arch Virol 119, 175-180.
37. Rancourt, R. C., Lee, R. L., O'Neill, H., Accurso, F. J. & White, C. W. (2007). Reduced thioredoxin increases proinflammatory cytokines and neutrophil influx in rat airways: modulation by airway mucus. Free Radic Biol Med 42, 1441-1453.
38. Reading, P. C., Morey, L. S., Crouch, E. C. & Anders, E. M. (1997). Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 71, 8204-8212.
39. Roberts, A., Deming, D., Paddock, C. D., Cheng, A., Yount, B., Vogel, L., Herman, B. D., Sheahan, T., Heise, M. & other authors (2007). A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog 3, e5.
40. Shieh, W. J., Hsiao, C. H., Paddock, C. D., Guarner, J., Goldsmith, C. S., Tatti, K., Packard, M., Mueller, L., Wu, M. Z. & other authors (2005). Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan. Hum Pathol 36, 303-309.
41. Sims, A. C., Baric, R. S., Yount, B., Burkett, S. E., Collins, P. L. & Pickles, R. J. (2005). Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol 79, 15511-15524.
42. Subbarao, K. & Roberts, A. (2006). Is there an ideal animal model for SARS? Trends Microbiol 14, 299-303.
43. To, K. F., Tong, J. H., Chan, P. K., Au, F. W., Chim, S. S., Chan, K. C., Cheung, J. L., Liu, E. Y., Tse, G. M. & other authors (2004). Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. J Pathol 202, 157-163.
44. Vabret, A., Dina, J., Gouarin, S., Petitjean, J., Tripey, V., Brouard, J. & Freymuth, F. (2008). Human (non-severe acute respiratory syndrome) coronavirus infections in hospitalised children in France. J Paediatr Child Health 44, 176-181.
45. van den Brand, J. M., Haagmans, B. L., Leijten, L., van Riel, D., Martina, B. E., Osterhaus, A. D. & Kuiken, T. (2008). Pathology of experimental SARS coronavirus infection in cats and ferrets. Vet Pathol 45, 551-562.
46. van der Hoek, L., Pyrc, K., Jebbink, M. F., Vermeulen-Oost, W., Berkhout, R. J., Wolthers, K. C., Wertheim-van Dillen, P. M., Kaandorp, J., Spaargaren, J. & Berkhout, B. (2004). Identification of a new human coronavirus. Nat Med 10, 368-373.
47. Wang, J., Oberley-Deegan, R., Wang, S., Nikrad, M., Funk, C. J., Hartshorn, K. L. & Mason, R. J. (2009). Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-λ1) in response to influenza A infection. J Immunol 182, 1296-1304.
48. Weiss, S. R. & Navas-Martin, S. (2005). Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev 69, 635-664.
49. WHO (2004). The World Health Report 2004: Changing History. World Health Organization.
50. Wojcinski, Z. W. & Percy, D. H. (1986). Sialodacryoadenitis virus-associated lesions in the lower respiratory tract of rats. Vet Pathol 23, 278-286.
51. Wong, C. K., Lam, C. W., Wu, A. K., Ip, W. K., Lee, N. L., Chan, I. H., Lit, L. C., Hui, D. S., Chan, M. H. & other authors (2004). Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136, 95-103.
52. Woo, P. C., Lau, S. K., Chu, C. M., Chan, K. H., Tsoi, H. W., Huang, Y., Wong, B. H., Poon, R. W., Cai, J. J. & other authors (2005). Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 79, 884-895.